Loading...
Thumbnail Image
Publication

A fluopol-ABPP HTS assay to identify PAD inhibitors

Knuckley, Bryan
Jones, Justin E.
Bachovchin, Daniel A.
Slack, Jessica
Causey, Corey P.
Brown, Steven J.
Rosen, Hugh
Cravatt, Benjamin F.
Thompson, Paul R
Embargo Expiration Date
Abstract

Protein Arginine Deiminase (PAD) activity is dysregulated in numerous diseases, e.g., Rheumatoid Arthritis. Herein we describe the development of a fluorescence polarization-Activity Based Protein Profiling (fluopol-ABPP) based high throughput screening assay that can be used to identify PAD-selective inhibitors. Using this assay, streptonigrin was identified as a potent, selective, and irreversible PAD4 inactivator.

Source

Chem Commun (Camb). 2010 Oct 14;46(38):7175-7. doi: 10.1039/c0cc02634d. Link to article on publisher's site. Epub 2010 Aug 25.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1039/c0cc02634d
PubMed ID
Other Identifiers
Notes

At the time of publication, Paul Thompson was not yet affiliated with UMass Medical School.

Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License